Timing of Cholecystectomy After Moderate and Severe Acute Biliary Pancreatitis
JAMA Surgery · 11.10.2023 · 158 (10) · e233660
DOI: 10.1001/jamasurg.2023.3660 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, online erschienen am 11.10.2023. Verfasst von Marcello Di Martino und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Liver Transplantation Surgery, A.O.R.N. Cardarelli, Naples, Italy. Hauptthemen laut MEDLINE: Gallstones, Pancreatitis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Importance Considering the lack of equipoise regarding the timing of cholecystectomy in patients with moderately severe and severe acute biliary pancreatitis (ABP), it is critical to assess this issue.
Objective
To assess the outcomes of early cholecystectomy (EC) in patients with moderately severe and severe ABP. Design, Settings, and Participants This cohort study retrospectively analyzed real-life data from the MANCTRA-1 (Compliance With Evidence-Based Clinical Guidelines in the Management of Acute Biliary Pancreatitis) data set, assessing 5304 consecutive patients hospitalized between January 1, 2019, and December 31, 2020, for ABP from 42 countries. A total of 3696 patients who were hospitalized for ABP and underwent cholecystectomy were included in the analysis; of these, 1202 underwent EC, defined as a cholecystectomy performed within 14 days of admission. Univariable and multivariable logistic regression models were used to identify prognostic factors of mortality and morbidity. Data analysis was performed from January to February 2023. Main Outcomes Mortality and morbidity after EC.
Results
Of the 3696 patients (mean [SD] age, 58.5 [17.8] years; 1907 [51.5%] female) included in the analysis, 1202 (32.5%) underwent EC and 2494 (67.5%) underwent delayed cholecystectomy (DC). Overall, EC presented an increased risk of postoperative mortality (1.4% vs 0.1%, P < .001) and morbidity (7.7% vs 3.7%, P < .001) compared with DC. On the multivariable analysis, moderately severe and severe ABP were associated with increased mortality (odds ratio [OR], 361.46; 95% CI, 2.28-57 212.31; P = .02) and morbidity (OR, 2.64; 95% CI, 1.35-5.19; P = .005). In patients with moderately severe and severe ABP (n = 108), EC was associated with an increased risk of mortality (16 [15.5%] vs 0 [0%], P < .001), morbidity (30 [30.3%] vs 57 [5.5%], P < .001), bile leakage (2 [2.4%] vs 4 [0.4%], P = .02), and infections (12 [14.6%] vs 4 [0.4%], P < .001) compared with patients with mild ABP who underwent EC. In patients with moderately severe and severe ABP (n = 108), EC was associated with higher mortality (16 [15.5%] vs 2 [1.2%], P < .001), morbidity (30 [30.3%] vs 17 [10.3%], P < .001), and infections (12 [14.6%] vs 2 [1.3%], P < .001) compared with patients with moderately severe and severe ABP who underwent DC. On the multivariable analysis, the patient’s age (OR, 1.12; 95% CI, 1.02-1.36; P = .03) and American Society of Anesthesiologists score (OR, 5.91; 95% CI, 1.06-32.78; P = .04) were associated with mortality; severe complications of ABP were associated with increased mortality (OR, 50.04; 95% CI, 2.37-1058.01; P = .01) and morbidity (OR, 33.64; 95% CI, 3.19-354.73; P = .003). Conclusions and Relevance This cohort study’s findings suggest that EC should be considered carefully in patients with moderately severe and severe ABP, as it was associated with increased postoperative mortality and morbidity. However, older and more fragile patients manifesting severe complications related to ABP should most likely not be considered for EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hepatobiliary and Liver Transplantation Surgery, A.O.R.N. Cardarelli, Naples, Italy.
- Hepatobiliary Surgery Unit, Hospital del Mar, Barcelona, Spain.
- Department of Surgery, Nicola Giannettasio Hospital, Corigliano-Rossano, Italy.
- Department of Pharmacy, Health, and Nutritional Sciences, University of Calabria, Rende, Italy.
- Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania, Luigi Vanvitelli, Naples, Italy.
- Colorectal Surgery Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Förderung
- Medical Research Council
Zitieren
APA
Di Martino, M., Ielpo, B., Pata, F., Pellino, G., Di Saverio, S., Catena, F., De Simone, B., Coccolini, F., Sartelli, M., Damaskos, D., Mole, D., Murzi, V., Leppaniemi, A., Pisanu, A., Podda, M., & MANCTRA-1 Collaborative Group (2023). Timing of Cholecystectomy After Moderate and Severe Acute Biliary Pancreatitis. JAMA Surgery, 158(10), e233660. https://doi.org/10.1001/jamasurg.2023.3660
Vancouver
Di Martino M, Ielpo B, Pata F, Pellino G, Di Saverio S, Catena F, et al. Timing of Cholecystectomy After Moderate and Severe Acute Biliary Pancreatitis. JAMA Surgery. 2023;158(10):e233660. doi:10.1001/jamasurg.2023.3660
BibTeX
@article{DiMartino2023,
author = {Di Martino, Marcello and Ielpo, Benedetto and Pata, Francesco and Pellino, Gianluca and Di Saverio, Salomone and Catena, Fausto and De Simone, Belinda and Coccolini, Federico and Sartelli, Massimo and Damaskos, Dimitrios and Mole, Damian and Murzi, Valentina and Leppaniemi, Ari and Pisanu, Adolfo and Podda, Mauro and MANCTRA-1 Collaborative Group, MANCTRA-1 Collaborative Group},
title = {Timing of Cholecystectomy After Moderate and Severe Acute Biliary Pancreatitis},
journal = {JAMA Surgery},
year = {2023},
volume = {158},
number = {10},
pages = {e233660},
doi = {10.1001/jamasurg.2023.3660}
}
EUVIMED